Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Awakn Life Sciences Corp (AWKNF)

Awakn Life Sciences Corp (AWKNF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Awakn Life Sciences Announces Collaboration Agreement with Graft Polymer (UK) PLC Newsfile - Thu Jul 18, 6:34AM CDT

Toronto, Ontario--(Newsfile Corp. - July 18, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company"), a clinical-stage biotechnology company developing therapeutics...

AWKNF : 0.0950 (+21.48%)
AWKN.CN : 0.1250 (+4.17%)
Awakn Life Sciences Announces Closing of Tranche of Private Placement Newsfile - Tue Jun 4, 6:42AM CDT

Toronto, Ontario--(Newsfile Corp. - June 4, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company") a clinical-stage biotechnology company developing medication-assisted...

AWKNF : 0.0950 (+21.48%)
AWKN.CN : 0.1250 (+4.17%)
Awakn Life Sciences Discusses Filing of Financial Statements Newsfile - Thu May 2, 5:16PM CDT

Toronto, Ontario--(Newsfile Corp. - May 2, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company"), a clinical-stage biotechnology company developing medication-assisted...

AWKNF : 0.0950 (+21.48%)
AWKN.CN : 0.1250 (+4.17%)
Awakn Life Sciences Announces Closing of Tranche of Private Placement Newsfile - Wed Apr 17, 6:34AM CDT

Toronto, Ontario--(Newsfile Corp. - April 17, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company") a clinical-stage biotechnology company developing medication-assisted...

AWKNF : 0.0950 (+21.48%)
AWKN.CN : 0.1250 (+4.17%)
Awakn Life Sciences Announces Launch of Licensing Partnership Agreement with Oklahoma Based Clinic Newsfile - Wed Apr 3, 6:32AM CDT

Awakn also announces Private PlacementToronto, Ontario--(Newsfile Corp. - April 3, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company") a clinical-stage biotechnology...

AWKNF : 0.0950 (+21.48%)
AWKN.CN : 0.1250 (+4.17%)
Awakn Life Sciences Announces Listing on the Canadian Securities Exchange Newsfile - Mon Feb 12, 6:46AM CST

Toronto, Ontario--(Newsfile Corp. - February 12, 2024) - Awakn Life Sciences Corp. (CBOE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn"), a clinical-stage biotechnology company developing medication-assisted...

AWKNF : 0.0950 (+21.48%)
AWKN.CN : 0.1250 (+4.17%)
AWKN.NE : 0.1100 (-21.43%)
Awakn Life Sciences Announces Conditional Approval of CSE Listing Newsfile - Mon Feb 5, 6:36AM CST

Toronto, Ontario--(Newsfile Corp. - February 5, 2024) - Awakn Life Sciences Corp. (CBOE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn"), a clinical-stage biotechnology company developing medication-assisted...

AWKNF : 0.0950 (+21.48%)
AWKN.NE : 0.1100 (-21.43%)
Awakn Life Sciences Completes Successful Investigative Study to Establish Dissociative Effect of a Proprietary Sublingual S-Ketamine Oral Thin Film Formulation in Harmful Drinkers Newsfile - Wed Jan 24, 6:36AM CST

Awakn Designates Program AWKN-002 for Alcohol Use Disorders in the US MarketToronto, Ontario--(Newsfile Corp. - January 24, 2024) - Awakn Life Sciences Corp. (CBOE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn"),...

AWKNF : 0.0950 (+21.48%)
AWKN.NE : 0.1100 (-21.43%)
Awakn Life Sciences Enters Global Licensing Agreement For Proprietary Sublingual S-Ketamine Formulation With LTS Newsfile - Wed Dec 20, 2023

Agreement Includes Exclusive Rights for Treatment of Addiction, Anxiety and Eating DisordersAlso Includes Access to Phase 1 Data and Patents Filed in US and Key International MarketsToronto, Ontario--(Newsfile...

AWKNF : 0.0950 (+21.48%)
AWKN.NE : 0.1100 (-21.43%)
Awakn Life Sciences Provides Corporate Update Newsfile - Fri Dec 15, 2023

Toronto, Ontario--(Newsfile Corp. - December 15, 2023) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) (“Awakn”), a clinical-stage biotechnology company developing therapeutics to...

AWKNF : 0.0950 (+21.48%)
AWKN.NE : 0.1100 (-21.43%)

Barchart Exclusives

Is Nvidia Stock a High-Risk Play Ahead of the U.S. Election? Barchart - 44 minutes ago
As the 2024 U.S. election approaches, Nvidia stock is experiencing volatility. Still, its stellar financial performance, driven by its dominance in AI technologies, suggest NVDA may be a smart buy on pullbacks. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot